Annual Conference 2013

020 - Heart Health: Hypertension, Cardiac, and Hypercholesterolemia

Sep 18, 2013 12:00pm ‐ Sep 18, 2013 5:00pm

Standard: $40.00
Members: $0.00

Description

A major component of the geriatric nurse practitioner’s role is managing the drug regimens of their patients. This workshop focuses on the heart health of the geriatric patient, including a specific focus on hypertension, dyslipidemia, and dysrhythmias (including use of anticoagulants). Application of pharmacokinetics, pharmacodynamics, indications, dosing, and toxicity are discussed. Recent studies and current controversies in the management of these disease states are also shared. Interactive case studies are utilized to apply the concepts discussed above.


Contact hours available until 9/21/2015.


Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.


Conflict of Interest Disclosure:
Robert DiDomenico discloses that he is a faculty member/speaker for ""CAPs: Creating Anticoagulation Plans to Prevent Stroke in Patients with Atrial Fibrillation"" CE program (Paradigm Medical Communications).
Vicki Groo discloses that she is a member of the speakers’ bureaus for Boehringer Ingelheim, Pfizer, and Bristol Myers Squibb; and that she served on the advisory board for Janssen Pharmaceuticals.


Planning Committee members have no disclosures to declare.


Commercial Support and Sponsorship:
The program is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc


Accreditation Statement:
This educational activity has been co-provided by Anthony J. Jannetti, Inc. and GAPNA.

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number, CEP 5387.


Objectives:

  • Review the pharmacology of common cardiovascular medications, including antihypertensives, lipid-lowering therapies, antiarrhythmic drugs, and anticoagulants .
  • Discuss the current controversies in the management of hypertension and dyslipidemia.
  • Evaluate the risks-benefit profiles of using anticoagulants, lipid-lowering therapies, and antiarrhythmic drugs in elderly patients.
  • Utilize a case-based approach to individualize therapy in elderly patients with hypertension, dyslipidemia, and dysrhythmias.

Speaker(s):

You must be logged in and own this session in order to post comments.